Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ryan Miller

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Molecular Pharmaceutics|January 18, 2018
Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical ResectionElizabeth Graham-Gurysh, Kathryn M Moore, Andrew B Satterlee, et al.
Cancer|April 8, 2011
The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastasesCarey K Anders, Allison M Deal, C Ryan Miller, et al.
Cancer Gene Therapy|January 15, 2005
Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitizationCharles Conrad, C Ryan Miller, Yongjie Ji, et al.
Science Translational Medicine|February 3, 2017
Tumor-homing cytotoxic human induced neural stem cells for cancer therapyJuli R Bagó, Onyi Okolie, Raluca Dumitru, et al.
Neuro-Oncology|September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Veterinary and Comparative Oncology|July 20, 2022
Inter-pathologist agreement on diagnosis, classification and grading of canine gliomaGregory A Krane, Keith R Shockley, David E Malarkey, et al.
Neuro-Oncology|November 23, 2022
Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Neuro-Oncology|February 13, 2019
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensusDavid Schiff, Martin Van den Bent, Michael A Vogelbaum, et al.
Neuro-Oncology|July 2, 2013
Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesisMark Vitucci, Natalie O Karpinich, Ryan E Bash, et al.
Journal of Neurochemistry|May 2, 2023
Relationships between gene expression and behavior in mice in response to systemic modulation of the O-GlcNAcylation pathwayMargaret B Bell, Xiaosen Ouyang, Abigail K Shelton, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Molecular Pharmaceutics|January 18, 2018
Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical ResectionElizabeth Graham-Gurysh, Kathryn M Moore, Andrew B Satterlee, et al.
Cancer|April 8, 2011
The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastasesCarey K Anders, Allison M Deal, C Ryan Miller, et al.
Cancer Gene Therapy|January 15, 2005
Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitizationCharles Conrad, C Ryan Miller, Yongjie Ji, et al.
Science Translational Medicine|February 3, 2017
Tumor-homing cytotoxic human induced neural stem cells for cancer therapyJuli R Bagó, Onyi Okolie, Raluca Dumitru, et al.
Neuro-Oncology|September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Veterinary and Comparative Oncology|July 20, 2022
Inter-pathologist agreement on diagnosis, classification and grading of canine gliomaGregory A Krane, Keith R Shockley, David E Malarkey, et al.
Neuro-Oncology|November 23, 2022
Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastomaBenjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Neuro-Oncology|February 13, 2019
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensusDavid Schiff, Martin Van den Bent, Michael A Vogelbaum, et al.
Neuro-Oncology|July 2, 2013
Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesisMark Vitucci, Natalie O Karpinich, Ryan E Bash, et al.
Journal of Neurochemistry|May 2, 2023
Relationships between gene expression and behavior in mice in response to systemic modulation of the O-GlcNAcylation pathwayMargaret B Bell, Xiaosen Ouyang, Abigail K Shelton, et al.
Pageof 12